Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 April 2020 | Story Department of Communication and Marketing | Photo Charl Devenish
Farmovs
In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.

The University of the Free State (UFS) is committed to supporting government’s efforts to overcome the COVID-19 pandemic. During this challenging time, dedicated staff members at the UFS continue to provide services as a testimony to their commitment to advance public knowledge of COVID-19 for the greater good of South Africa.

The following is a synopsis of the areas in which the UFS is actively assisting.

Public Health Emergency Solidarity Trial
Clinicians from the Department of Internal Medicine, the Department of Critical Care, and the Division of Virology will be working with FARMOVS to participate in the Public Health Emergency Solidarity Trial initiated by the World Health Organization (WHO). This international randomised trial will evaluate four treatment options (remdesivir, lopinavir/ritonavir, lopinavir/ritonavir plus interferon, chloroquine or hydroxychloroquine) for the treatment of COVID-19. 

The trial is expected to include more than 45 countries worldwide, including a number of South African sites. 

Farmovs

FARMOVS is in a planning process to support all the Bloemfontein hospitals, including Pelonomi, Universitas, 3 Military Hospital, Mediclinic, and Rosepark, in conducting the largest global trial on COVID-19 – the Public Health Emergency Solidarity Trial, under leadership of the WHO.   

Negotiations are ongoing between the UFS and the Department of Health in the Free State for FARMOVS to offer support with the continuation of healthcare to non-COVID-19 patients in an attempt to free up space at Universitas Hospital for isolation of COVID-19 patients. 

In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.  FARMOVS also receives feasibility requests for support with the evaluation of existing drugs (repurposing) as well as the development of novel drugs for the treatment of COVID-19 – this is an ongoing process.

Disaster Management Training and Education Centre (DiMTEC)
DiMTEC represents the UFS on the Provincial Joint Operation Centre (PROVJOC). The PROVJOC is a fully equipped, dedicated facility that is proactively established to enable all relevant role players /disciplines to jointly manage all safety and security-related aspects of any planned event or any major incident which has occurred or is imminent – especially in the response and recovery operations phase – at the strategic and/or tactical level, using the Unified Command System. This facility is also linked to all other established safety and security centres.

Research and Innovation
The UFS hosts a SARChI Research Chair in vector-borne and zoonotic diseases, and recently invested in the establishment of a biosafety level-3 facility. Hence, there is expertise on the campus to plan and conduct research on zoonotic and medically significant viruses. In addition, there are research groups focusing on protein expression systems with potential for utilisation in the development of diagnostic assays with application in either diagnosis or surveillance.

Currently, researchers at the UFS have established several projects that will contribute directly towards the COVID-19 outbreak.


News Archive

Tutu-Jonker Prestige Lecture Series tackles reconciliation
2017-11-13

Description: ' 000 a Tutu Jonker Prestige Lecture Tags: Tutu Jonker Prestige Lecture

Prof Rian Venter; Prof Eddy van der Borght, guest speaker from Vrije
Universiteit, Amsterdam; and Prof Fanie Snyman, Dean of the Faculty
of Theology and Religion at the UFS.
Photo: Supplied

The Faculty of Theology and Religion recently hosted the annual Tutu-Jonker Prestige Lecture Series at the Bloemfontein Campus of the University of the Free State (UFS). The purpose of the lecture series is to address modern-day and pressing social challenges from a theological and religious perspective.

With the theme Religions and reconciliation of conflicting identities, guest speaker and Desmond Tutu Chair on reconciliation at the Faculty of Theology: Vrije Universiteit Amsterdam, Prof Eddy van der Borght, spoke about the reformation in the context of shifting European identity formations.

Reconciliation versus social identity

“My focus is on what the Christian concept of reconciliation means for reconciliation in society,” said Prof Van der Borght. He deliberated the global problem of conflict generated by diverse social identities. He also emphasised that religion has huge resources to contribute towards overcoming conflicting identities.

“The theory is that religions know about reconciliation, while in practice it is much more complicated, because often religions are part of the problem of conflict,” he says. He said religions are often the problem in social cultural identities, especially regarding conflict involving different nations, racial, and ethnic groups.

Honouring prominent theologians Tutu and Jonker

The name Tutu-Jonker originates from the two theologians, Emeritus Archbishop Desmond Tutu and the late Prof Willie Jonker, who are both regarded as prominent theologians known for their emphasis on reconciliation in South Africa. The significance of combining the two names is said to bring together two different theological traditions (Anglican and Reformed), cultural groups, and races.

Prof Fanie Snyman, Dean of the Faculty of Theology and Religion, said, “This will also serve the purpose of a welcoming culture at the faculty, embracing diversity and embodying reconciliation.” Both of these theologians received honorary doctorates in Theology from the UFS.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept